Bridgewater Updates Portfolio with Additions and Reductions Across Tech Stocks

The evidence from the provided sources strongly and consistently supports the statement that Bridgewater's portfolio was updated to include both additions and reductions in technology stocks.Evidence for additions comes from two separate financial news outlets. A Yahoo Finance article explicitly states that Bridgewater established a position in Bitdeer Technologies Group, a technology company. Another article from 247wallst.com reports that the firm increased its stake in Nvidia (NVDA), a major technology stock. These two sources provide direct and compelling evidence for the 'additions' part of the claim.Evidence for reductions is provided by Fintel, a financial data provider that aggregates SEC filings. It shows that Bridgewater made a 100% reduction in its holding of Sarepta Therapeutics, Inc. (SRPT). Sarepta is a biopharmaceutical company, and biotechnology is widely considered a sub-sector of the technology industry in investment contexts. This directly supports the 'reductions' part of the claim.Several other sources were irrelevant as they were either corporate homepages (Sanofi, J&J, IQVIA), a product page (State Street), or a social media post about a different fund. However, the relevant sources are consistent and point to a clear conclusion. The presence of direct evidence for both adding and reducing positions in technology or technology-related sectors makes the statement highly likely to be true.